INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by AMAG Pharmaceuticals,...
November 19 2015 - 6:15PM
Business Wire
Levi & Korsinsky, LLP announces that it has commenced an
investigation of AMAG Pharmaceuticals, Inc. (“AMAG Pharmaceuticals”
or the “Company”) (NASDAQGS: AMAG) concerning possible violations
of federal securities laws by the Company and/or certain of its
officers and directors.
On November 18, 2015, AMAG Pharmaceuticals disclosed the receipt
of a Complete Response Letter from the U.S. Food and Drug
Administration for its application seeking approval for a
single-dose vial of Makena to reduce the risk of preterm birth in
certain at-risk patients. This is the second such letter from the
FDA this year. To obtain additional information about the
investigation, go to:
http://zlk.9nl.com/amag-pharmaceuticals-amag
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151119006793/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.30 Broad Street -
24th FloorNew York, NY 10004Tel: (212) 363-7500Toll Free: (877)
363-5972Fax: (212) 363-7171www.zlk.com
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024